Comparative RNA editing in autistic and neurotypical cerebella

Molecular Psychiatry

Volumn 18, Issue 9, 2013, Pages 1041-1048

  Eran, A ^a,b   Li, J B ^c   Vatalaro, K ^b   McCarthy, J ^b   Rahimov, F ^b,d   Collins, C ^b,d   Markianos, K ^b   Margulies, D M ^b,e,f   Brown, E N ^a,g,h   Calvo, S E ^h   Kohane, I S ^a,b,f   Kunkel, L M ^b,d,i  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c STANFORD UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Correlagen Diagnostics ^*  (United States)

^f Harvard Medical School Center for Biomedical Informatics   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

ⁱ Manton Center for Orphan Disease Research   (United States)

Author keywords

A to I; autism; epigenetics; human cerebellum; neurodevelopment; RNA editing

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; INOSINE;

ARTICLE; AUTISM; CEREBELLUM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; EPIGENETICS; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; PRIORITY JOURNAL; PROTEIN MODIFICATION; RNA EDITING; SYNAPSE;

ADENOSINE DEAMINASE; ADOLESCENT; AUTISTIC DISORDER; CEREBELLUM; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; FILAMINS; GENE LIBRARY; HUMANS; KV1.1 POTASSIUM CHANNEL; MALE; NUMERICAL ANALYSIS, COMPUTER-ASSISTED; PROTEIN ISOFORMS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, AMPA; RNA EDITING; TRANSCRIPTOME; YOUNG ADULT;

EID: 84883176120     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.118     Document Type: Article

References (75)

1. Jepson JE, Savva YA, Yokose C, Sugden AU, Sahin A, Reenan RA. Engineered alterations in RNA editing modulate complex behavior in Drosophila: regulatory diversity of adenosine deaminase acting on RNA (ADAR) targets. J Biol Chem 2011; 286: 8325-8337.
2. Mombereau C, Kawahara Y, Gundersen BB, Nishikura K, Blendy JA. Functional relevance of serotonin 2C receptor mRNA editing in antidepressant-and anxietylike behaviors. Neuropharmacology 2010; 59: 468-473.
3. Tonkin LA, Saccomanno L, Morse DP, Brodigan T, Krause M, Bass BL. RNA editing by ADARs is important for normal behavior in Caenorhabditis elegans. EMBO J 2002; 21: 6025-6035.
4. Maas S. Gene regulation through RNA editing. Discov Med 2010; 10: 379-386.
5. Mattick JS. RNA as the substrate for epigenome-environment interactions: rNA guidance of epigenetic processes and the expansion of RNA editing in animals underpins development, phenotypic plasticity, learning, and cognition. Bioessays 2010; 32: 548-552.
6. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 2010; 79: 321-349.
7. Lomeli H, Mosbacher J, Melcher T, Hoger T, Geiger JR, Kuner T et al. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 1994; 266: 1709-1713.
8. Kohler M, Burnashev N, Sakmann B, Seeburg PH. Determinants of Ca2\+ permeability in both TM1 and TM2 of high affinity kainate receptor channels: diversity by RNA editing. Neuron 1993; 10: 491-500.
9. Rula EY, Lagrange AH, Jacobs MM, Hu N, Macdonald RL, Emeson RB. Developmental modulation of GABA(A) receptor function by RNA editing. J Neurosci 2008; 28: 6196-6201.
10. Feldmeyer D, Kask K, Brusa R, Kornau HC, Kolhekar R, Rozov A et al. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat Neurosci 1999; 2: 57-64.
11. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997; 387: 303-308.
12. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 2007; 315: 1137-1140.
13. Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep 2007; 8: 763-769.
14. Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 2006; 13: 13-21.
15. Borchert GM, Gilmore BL, Spengler RM, Xing Y, Lanier W, Bhattacharya D et al. Adenosine deamination in human transcripts generates novel microRNA binding sites. Hum Mol Genet 2009; 18: 4801-4807.
16. Mehler MF, Mattick JS. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev 2007; 87: 799-823.
17. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, Leproust E et al. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009; 324: 1210-1213.
18. Mattick JS, Mehler MF. RNA editing, DNA recoding and the evolution of human cognition. Trends Neurosci 2008; 31: 227-233.
19. Garrett S, Rosenthal JJ. RNA editing underlies temperature adaptation in K\+ channels from polar octopuses. Science 2012; 335: 848-851.
20. Macbeth MR, Schubert HL, Vandemark AP, Lingam AT, Hill CP, Bass BL. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 2005; 309: 1534-1539.
21. Patterson JB, Samuel CE. Expression and regulation by interferon of a doublestranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 1995; 15: 5376-5388.
22. Englander MT, Dulawa SC, Bhansali P, Schmauss C. How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J Neurosci 2005; 25: 648-651.
23. Wahlstedt H, Daniel C, Enstero M, Ohman M. Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res 2009; 19: 978-986.
24. Wulff BE, Nishikura K. Substitutional A-to-I RNA editing. WIREs RNA 2010; 1: 90-101.
25. Jepson JE, Reenan RA. RNA editing in regulating gene expression in the brain. Biochim Biophys Acta 2008; 1779: 459-470.
26. Peng Z, Cheng Y, Tan BC, Kang L, Tian Z, Zhu Y et al. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat Biotechnol 2012; 30: 253-260.
27. Athanasiadis A, Rich A, Maas S. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol 2004; 2: e391.
28. Paz-Yaacov N, Levanon EY, Nevo E, Kinar Y, Harmelin A, Jacob-Hirsch J et al. Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates. Proc Natl Acad Sci USA 2010; 107: 12174-12179.
29. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 2010; 26: 363-372.
30. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011; 474: 380-384.
31. Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol 2009; 19: 231-234.
32. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011; 70: 898-907.
33. Anney RJ, Kenny EM, O'Dushlaine C, Yaspan BL, Parkhomenka E, Buxbaum JD et al. Gene-ontology enrichment analysis in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders. Eur J Hum Genet 2011; 19: 1082-1089.
34. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466: 368-372.
35. Sakai Y, Shaw CA, Dawson BC, Dugas DV, Al-Mohtaseb Z, Hill DE et al. Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med 2011; 3: 86ra49.
36. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011; 68: 1095-1102.
37. Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 255-274.
38. Grafodatskaya D, Chung B, Szatmari P, Weksberg R. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry 2010; 49: 794-809.
39. Singh M, Zimmerman MB, Beltz TG, Johnson AK. Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2. Physiol Behav 2009; 97: 446-454.
40. Jepson JE, Savva YA, Yokose C, Sugden AU, Sahin A, Reenan RA. Engineered alterations in RNA editing modulate complex behavior in Drosophila: regulatory diversity of adenosine deaminase acting on RNA (ADAR) targets. J Biol Chem 2011; 286: 8325-8337.
41. Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS et al. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis 2010; 39: 169-180.
42. Canitano R. Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry 2007; 16: 61-66.
43. Veltman MW, Craig EE, Bolton PF. Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review. Psychiatr Genet 2005; 15: 243-254.
44. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 2009; 137: 1235-1246.
45. Daniels JL, Forssen U, Hultman CM, Cnattingius S, Savitz DA, Feychting M et al. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics 2008; 121: e1357-e1362.
46. Sodhi MS, Burnet PW, Makoff AJ, Kerwin RW, Harrison PJ. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol Psychiatry 2001; 6: 373-379.
47. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002; 34: 349-356.
48. Hagerman R, Hoem G, Hagerman P. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Mol Autism 2010; 1: 12.
49. Bhogal B, Jepson JE, Savva YA, Pepper AS, Reenan RA, Jongens TA. Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein. Nat Neurosci 2011; 14: 1517-1524.
50. Peca J, Ting J, Feng G. SnapShot: autism and the synapse. Cell 2011; 147: 706.
51. Stephenson DT, O'Neill SM, Narayan S, Tiwari A, Arnold E, Samaroo HD et al. Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Mol Autism 2011; 2: 7.
52. Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet 2011; 20: 3093-3108.
53. Gai X, Xie HM, Perin JC, Takahashi N, Murphy K, Wenocur AS et al. Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry 2012; 17: 402-411.
54. Farra N, Zhang WB, Pasceri P, Eubanks JH, Salter MW, Ellis J. Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol Psychiatry; advance online publication, 10 January 2012; doi:10.1038/mp.2011.180.
55. Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, Seilhean D et al. Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol 2010; 69: 70-81.
56. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005; 437: 376-380.
57. Shamir R, Maron-Katz A, Tanay A, Linhart C, Steinfeld I, Sharan R et al. EXPANDER-an integrative program suite for microarray data analysis. BMC Bioinform 2005; 6: 232.
58. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc 1995; 57: 125-133.
59. Belcher SM, Howe JR. Characterization of RNA editing of the glutamate-receptor subunits GluR5 and GluR6 in granule cells during cerebellar development. Brain Res Mol Brain Res 1997; 52: 130-138.
60. Bhalla T, Rosenthal JJ, Holmgren M, Reenan R. Control of human potassium channel inactivation by editing of a small mRNA hairpin. Nat Struct Mol Biol 2004; 11: 950-956.
61. Nishikura K. Editor meets silencer: crosstalk between RNA editing and RNA interference. Nat Rev Mol Cell Biol 2006; 7: 919-931.
62. Abrahams BS, Geschwind DH. Connecting genes to brain in the autism spectrum disorders. Arch Neurol 2010; 67: 395-399.
63. Mostofsky SH, Powell SK, Simmonds DJ, Goldberg MC, Caffo B, Pekar JJ. Decreased connectivity and cerebellar activity in autism during motor task performance. Brain 2009; 132(Part 9): 2413-2425.
64. Palmen SJ, van Engeland H, Hof PR, Schmitz C. Neuropathological findings in autism. Brain 2004; 127(Part 12): 2572-2583.
65. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNAediting enzyme ADAR2. Nature 2000; 406: 78-81.
66. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008; 9: 341-355.
67. Rueter SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature 1999; 399: 75-80.
68. Kawahara Y, Ito K, Ito M, Tsuji S, Kwak S. Novel splice variants of human ADAR2 mRNA: skipping of the exon encoding the dsRNA-binding domains, and multiple C-terminal splice sites. Gene 2005; 363: 193-201.
69. Levanon EY, Hallegger M, Kinar Y, Shemesh R, Djinovic-Carugo K, Rechavi G et al. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res 2005; 33: 1162-1168.
70. Dracheva S, Lyddon R, Barley K, Marcus SM, Hurd YL, Byne WM. Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral trait. Neuropsychopharmacology 2009; 34: 2237-2251.
71. Du Y, Stasko M, Costa AC, Davisson MT, Gardiner KJ. Editing of the serotonin 2C receptor pre-mRNA: Effects of the Morris Water Maze. Gene 2007; 391: 186-197.
72. Auerbach BD, Osterweil EK, Bear MF. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011; 480: 63-68.
73. Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 2012; 17: 290-314.
74. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K et al. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 2008; 30: 303-311.
75. Lainhart JE, Lange N. Increased neuron number and head size in autism. JAMA 2011; 306: 2031-2032.